Texas Children's Hospital, Baylor College of Medicine
Houston, Texas, 77030, United States
NCT Number: NCT01057381
The hypothesis of this study is that the administration of an intra-operative dose of dexmedetomidine will result in adequate analgesia without respiratory depression thereby resulting in an early discharge from the post anesthetic care unit following adenotonsillectomy.
Looking for future studies?
Notify Me3 year–17 year
All sexes
Interventional
Phase 4
Houston, Texas, 77030, United States
Dexmedetomidine, an alpha 2 agonist provides some analgesia without respiratory depression. Children undergoing tonsillectomy and adenoidectomy occasionally have episodes of respiratory obstruction in the recovery room following administration of opioids.
As dexmedetomidine provides some analgesia without respiratory depression,an intra-operative dose of dexmedetomidine may provide adequate analgesia without significant side effects thereby allowing for quick post operative recovery.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Single intra-operative administration of dexmedetomidine 0.75 mcg/kg over 10 minutes for analgesia.
Other names: Precedex
Single intra-operative administration of morphine 50 mcg/kg over 10 minutes for analgesia
Other names: Morphine
Single intra-operative dose of morphine 100 mcg/kg over 10 minutes for analgesia
Other names: Morphine
Single intra-operative administration of dexmedetomidine 1 mcg/kg over 10 minutes for analgesia
Other names: Precedex
Time frame: From admission to discharge from PACU, up to 1 hour
Time frame: From admission to discharge from PACU, up to 1 hour
Subjects with a Children's Hospital of Eastern Ontario Pain Scale score greater than 8 received rescue morphine doses of 25 ug/kg IV at 10-minute intervals until the score was less than 8.
Minimum and Maximum values: minimum score: 4 & maximum score: 13. The higher the score ( > 8), the greater the pain appreciated by the patient.
Time frame: From admission to PACU until room air saturations greater than or equal to 95% for 5 minutes
The subjects were then transported to the PACU with supplemental oxygen. Oxygen administration was continued after extubation until the patient was awake and could sustain room air saturations greater than 95% for 5 minutes. Duration of oxygen requirement was recorded as the time from tracheal extubation to cessation of oxygen supplementation in the PACU.
Time frame: From admission to discharge from PACU, no time limit
Patients were considered ready for discharge from the PACU when they attained an Aldrete score of 9 or more and were free from pain, nausea, and vomiting. Aldrete score ranges form 0 to 10 and patients greater than 8 are deemed satisfactory for discharge from the PACU
Time frame: From admission to discharge from PACU, no time limit
Patients in the PACU who were crying, restless, disoriented, unresponsive to the parent's voice, with non-purposeful thrashing movements requiring additional personnel to prevent bodily harm, and inconsolable even after parental presence, rescue analgesia and additional measures of comfort were considered to have emergence agitation.
Time frame: From admission to discharge from PACU, up to 1 hour
Post-operative complications including emesis, prolonged oxygen requirement or post- tonsillectomy bleed assessed up to 1 hour in PACU
Baylor College of Medicine
Other
Dose Response Relationship of Dexmedetomidine in Decreasing Post Operative Analgesic Requirements in the Pediatric Tonsillectomy Patient
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07508202
Dexmedetomidine, Post Operative Analgesia
Islamabad, Federal, Pakistan
View Trial DetailsNCT06658574
Agnosia, Bariatric Surgery
New Brunswick, New Jersey, United States
View Trial DetailsNCT07646093
Neurologic Manifestations, Pain
Caracas, Miranda, Venezuela
View Trial DetailsNCT06728514
Cardiovascular Diseases, Hemodynamic (MAP) Stability
Sahiwal, Punjab Province, Pakistan
View Trial Details